A bispecific antibody-based approach for targeting mesothelin in triple negative breast cancer

HIGHLIGHTS

• who: Brigitte Kerfelec from the Biologie du Développement de, UMR7288, France Tel Aviv University, Israel have published the research work: A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer, in the Journal: (JOURNAL)
• what: In this study, multicellular tumor spheroids of TNBC were developed in parallel with conventional 2D cell monolayers. The authors show that MesobsFab enhanced NK cell recruitment and increased the number and the probability of NK cell penetration in deeper distances compared to NK cell/spheroids alone.
• how: This result was observed at all ET . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.